Foreign residents in Japan may soon face higher out-of-pocket costs when receiving prescription medications that have similar over-the-counter equivalents, following a significant legislative development in the Japanese Diet. On April 24, 2026, the House of Representatives Committee on Health, Labour and Welfare passed amendments to the Health Insurance Act that would require patients to pay additional fees when prescribed medications classified as "OTC-similar drugs," according to NHK. The bill passed with majority support from both ruling and opposition parties, marking a major step toward implementation of this cost-sharing measure. The term "OTC-similar drugs" refers to prescription medications that contain similar active ingredients or have comparable therapeutic effects to medicines available over-the-counter at pharmacies without a prescription. Common examples in this category typically include certain pain relievers, cold medications, antihistamines for allergies, and digestive aids that exist in both prescription and non-prescription forms. The rationale behind this legislative change centers on healthcare cost containment. Japan's national health insurance system faces mounting financial pressures due to the country's rapidly aging population and increasing medical expenditures. By introducing additional patient co-payments for medications that could reasonably be purchased without a prescription, policymakers aim to encourage patients to choose OTC alternatives when appropriate, thereby reducing the burden on the public health insurance system. For expats living in Japan who are enrolled in either the National Health Insurance (kokumin kenko hoken) or Employee Health Insurance (shakai hoken), this change could affect routine medical care. Currently, patients in Japan typically pay 30% of medical costs at the point of service, with the insurance system covering the remaining 70%. Under the proposed amendments, patients receiving OTC-similar drugs would face an additional charge on top of the standard co-payment, though the exact amount of this surcharge has not been specified in the available reports. The committee approval represents a crucial procedural step in Japan's legislative process. For the amendments to become law, the bill must still pass a full vote in the House of Representatives and subsequently receive approval from the House of Councillors. Given the bipartisan support demonstrated in committee, passage through the remaining legislative stages appears likely, though the timeline for final implementation remains unclear. Foreign residents should be aware that this development is part of broader healthcare reforms being discussed in Japan. The government has been exploring various measures to ensure the sustainability of the national health insurance system while maintaining quality care. Previous reforms have included adjustments to co-payment rates for certain age groups and the introduction of fees for outpatient services at large hospitals without referrals. Practical implications for expats will depend on their individual health needs and prescription patterns. Those who regularly receive prescriptions for medications that have OTC equivalents may want to discuss alternatives with their healthcare providers. In some cases, purchasing OTC versions directly might prove more economical than paying both the standard co-payment and the new additional charge for prescription versions. Language barriers can complicate healthcare navigation for non-Japanese speakers, making it especially important for expats to understand these changes. When the law takes effect, patients should ask their doctors whether prescribed medications fall into the OTC-similar category and what the cost implications might be. Many clinics serving international communities in major cities offer English-speaking staff who can help explain these distinctions. As Japan's healthcare system continues to evolve in response to demographic and fiscal challenges, foreign residents should stay informed about policy changes that may affect their medical expenses and treatment options. While the additional fees aim to promote more cost-effective healthcare choices, understanding how these changes apply to individual circumstances will be essential for managing healthcare costs effectively.